Physicians and scientists from the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham will present the latest in cancer science to the global oncology community in a new virtual format at the annual meeting of the American Society of Clinical Oncology on May 29-31. ASCO represents nearly 45,000 oncology professionals who care for people living with cancer.
O’Neal Comprehensive Cancer Center investigators are authors on more than 50 abstracts accepted by ASCO for the annual meeting. With this year’s theme of Unite and Conquer: Accelerating Progress Together, the scientific program will provide an engaging lineup of scheduled and on-demand scientific content across a variety of approaches, disciplines and specialties.
Advances in immunotherapies and targeted therapies for lung, colorectal and bladder cancers; improvements in access to cancer care; and the impact of COVID-19 on people with cancer are among the topics that will be highlighted during this year’s program.
Specifically, UAB’s cancer experts will present various studies on multiple myeloma, ovarian cancer, pediatric oncology and geriatric conditions associated with survival.
Oncologic radiologist Andrew Smith, M.D., Ph.D., associate professor in the Department of Radiology and director of UAB’s Tumor Metrics Lab, will present the results of a multi-institution clinical trial of artificial intelligence-assisted software to improve accuracy, reduce errors and increase speed in computed tomography scans of patient tumors. His presentation is titled “Multi-institutional Comparative Effectiveness of Advanced Cancer Longitudinal Response Evaluation: Current Practice vs. Artificial Intelligence.” Read an abstract of the study here.
Detailed information on all UAB abstracts is online; search University of Alabama at Birmingham.